This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bob Schieffer To Bring Greater Public Awareness To Bladder Cancer

BETHESDA, Md., March 20, 2013 /PRNewswire-USNewswire/ -- For the third straight year, CBS newsman and bladder cancer survivor Bob Schieffer has agreed to serve as honorary chair for the national Walks for Bladder Cancer Day set for Saturday, May 4, 2013.

The Bladder Cancer Advocacy Network (BCAN), the first national advocacy organization dedicated to advancing bladder cancer research, support and education, announced that Schieffer and other advocates in the Washington DC area will walk in our nation's capital to raise awareness of bladder cancer in addition to needed funds for research and education.   At the same time, thousands of other walkers across the country will also take to the streets of their local communities to bring attention and awareness to this very common, but unspoken of, disease.

In last year's effort, more than 5,000 people participated in 60 walks in 30 states to raise more than $275,000 to help foster research programs, patient education and public awareness.

Schieffer was diagnosed with bladder cancer several years ago after he noticed blood in his urine. Since then, he has repeatedly spoken out about his diagnosis. His openness about his disease has helped other bladder cancer survivors recognize that they are not alone and encouraged them to visit a doctor if they see symptoms.  Schieffer is the Chief Washington Correspondent for CBS News and has anchored Face the Nation since 1991.

Bladder cancer is a significant health concern. It is the sixth most commonly diagnosed cancer in the United States with more than 70,000 new cases and 15,000 deaths each year.  Still, there is little awareness of this devastating disease. Bladder cancer has a high recurrence rate and, because it requires life-long surveillance, is one of the most expensive cancers to treat on a per patient basis.  The causes of bladder cancer are not fully understood and there have been no major advances in its treatment in the last 20 years.

BCAN was created in May 2005 and is the leading voice for bladder cancer cultivating a community of hope and support for people touched by the disease.  BCAN's mission is to increase public awareness about bladder cancer, advance bladder cancer research, and provide educational and support services for the bladder cancer community.  For more information on how you can take part in a walk for bladder cancer in your community on May 4, 2013, please visit or call 888-901-BCAN.

SOURCE Bladder Cancer Advocacy Network

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs